HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Aradi Selected Research
Daniel Aradi Research Topics
Disease
14
Acute Coronary Syndrome
01/2022 - 04/2009
10
Hemorrhage
04/2021 - 09/2013
9
Thrombosis (Thrombus)
01/2020 - 11/2010
7
Myocardial Infarction
01/2022 - 01/2016
5
Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2017
4
ST Elevation Myocardial Infarction
01/2022 - 11/2010
2
Atherosclerotic Plaque (Atheroma)
01/2023 - 01/2022
2
Stroke (Strokes)
11/2020 - 01/2020
1
AIDS-Related Complex (ARC)
01/2022
1
Unstable Angina
01/2020
1
Patent Foramen Ovale
10/2019
1
Chronic Renal Insufficiency
10/2018
1
Ischemic Stroke
01/2018
1
Heart Arrest (Cardiac Arrest)
08/2017
1
Death (Near-Death Experience)
01/2016
1
Hypertension (High Blood Pressure)
11/2014
1
Type 2 Diabetes Mellitus (MODY)
11/2014
1
Ischemia
12/2013
1
Myocardial Ischemia (Ischemic Heart Diseases)
09/2013
1
Infarction (Infarctions)
11/2010
1
Pain (Aches)
11/2010
Drug/Important Bio-Agent (IBA)
9
Clopidogrel (Plavix)
FDA Link
01/2020 - 09/2013
5
Prasugrel Hydrochloride
FDA Link
01/2020 - 09/2018
4
Adenosine Diphosphate (ADP)
IBA
01/2020 - 12/2013
4
2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))
IBA
09/2019 - 01/2017
3
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
11/2017 - 09/2013
2
evolocumab
IBA
01/2023 - 01/2022
2
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
10/2018 - 09/2013
2
Ticagrelor
IBA
10/2018 - 01/2018
2
Cytochrome P-450 CYP2C19
IBA
09/2018 - 01/2016
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022
1
oxidized low density lipoprotein
IBA
01/2022
1
Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)
IBA
01/2022
1
Subtilisin
IBA
01/2022
1
Lipids
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Purinergic P2 Receptors (ADP Receptor)
IBA
04/2019
1
Diphosphates (Pyrophosphates)
IBA
10/2018
1
Purinergic P2Y Receptor Antagonists
IBA
10/2018
1
aliskiren
FDA Link
11/2014
1
Valsartan (Vals)
FDA Link
11/2014
1
Fibrinolytic Agents (Antithrombotic Agents)
IBA
11/2013
1
cangrelor
IBA
11/2013
Therapy/Procedure
12
Percutaneous Coronary Intervention
11/2020 - 11/2010
8
Stents
01/2020 - 11/2010
7
Therapeutics
08/2021 - 01/2015
2
Secondary Prevention
10/2019 - 01/2015
2
Induced Hypothermia
01/2019 - 08/2017
1
Heart-Assist Devices
10/2019
1
Thrombectomy
11/2010
1
Bone Wires
04/2009